Previous close | 21.98 |
Open | 24.60 |
Bid | 25.10 |
Ask | 26.30 |
Strike | 155.00 |
Expiry date | 2026-01-16 |
Day's range | 24.60 - 24.76 |
Contract range | N/A |
Volume | |
Open interest | 119 |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.